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Preface 
This dissertation has been prepared partly cumulative. The data obtained in the 
presented work has been described in detail in five publications, which are attached 
to the end of the thesis. 
1. Proteomic analyses reveal an acidic prime side specificity for the astacin 
metalloprotease family reflected by physiological substrates. 
Becker-Pauly C, Barré O, Schilling O, Auf dem Keller U, Ohler A, Broder C, Schütte 
A, Kappelhoff R, Stöcker W, Overall CM. 
Mol Cell Proteomics. 2011 Sep;10(9):M111.009233. 
2. Structural basis for the sheddase function of human meprin β 
metalloproteinase at the plasma membrane. 
Arolas JL, Broder C, Jefferson T, Guevara T, Sterchi EE, Bode W, Stöcker W, 
Becker-Pauly C, Gomis-Rüth FX. 
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16131-6.  
3. The substrate degradome of meprin metalloproteases reveals an unexpected 
proteolytic link between meprin β and ADAM10. 
Jefferson T, Auf dem Keller U, Bellac C, Metz VV, Broder C, Hedrich J, Ohler A, 
Maier W, Magdolen V, Sterchi E, Bond JS, Jayakumar A, Traupe H, Chalaris A, 
Rose-John S, Pietrzik CU, Postina R, Overall CM, Becker-Pauly C. 
Cell Mol Life Sci. 2013 Jan;70(2):309-33. 
4. The metalloproteases meprin α and meprin β: unique enzymes in 
inflammation, neurodegeneration, cancer and fibrosis. 
Broder C, Becker-Pauly C. 
Biochem J. 2013 Mar 1;450(2):253-64.  
5. The Metalloproteases Meprin α and Meprin β are C- and N-procollagen 
Proteinases Important for Collagen Assembly and Tensile Strength. 
Broder C, Arnold P, Vadon-Le Goff S, Konerding MA, Bahr K, Müller S, Overall CM, 
Bond JS, Koudelka T, Tholey A, Hulmes DJ, Moali C, Becker-Pauly C. 
Proc Natl Acad Sci U S A. 2013 in press. 
In the following, most relevant results from the publications 1-5 are briefly described 
and unpublished data are illustrated in detail.  
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Abstract 
Fibrillar collagen type I is the most abundant protein in human body and 
essential for the formation and strength of bone, skin, and tendon. The assembly of 
collagen fibrils is initiated by proteolytic enzymes which cleave off the propeptides of 
procollagen I. Hence, mutations in collagen genes and dysregulation of procollagen 
proteinase activity are the main causes of pathological disorders in collagen fibril 
formation. Here I demonstrate that the metalloproteases meprin α and meprin β are 
the only enzymes known so far capable of releasing the C- as well as the N-
propeptides from type I procollagen both in vitro and in vivo thereby inducing the 
assembly of collagen fibrils. Meprin cleavage sites were found to be the same or in 
close proximity to those for the N-proteinase ADAMTS-2 and the C-proteinase BMP-
1. Skin lysates from meprin α and meprin β knockout mice revealed smaller amounts 
of the mature collagen I compared to wild-type controls. As a consequence, meprin α 
and meprin β knockout mice exhibited significantly reduced collagen deposition in 
skin and an impaired arrangement of dermal collagen fibrils. This resulted in a 
markedly decreased tissue tensile strength. As a compensatory effect to partly offset 
the loss of procollagen proteinase activity in meprin knockout mice, expression of 
gene coding for bone morphogenetic protein-1/mammalian tolloid (BMP-1/mTLD) 
was significantly increased in these animals. These data demonstrate that meprin α 
and meprin β induce collagen fibril formation in vitro and in vivo and contribute to the 
integrity of connective tissue in skin. They regulate the collagen deposition in skin 
and might therefore be promising therapeutic targets to limit fibrosis.
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Zusammenfassung 
Fibrilläre Kollagene stellen die wichtigsten Proteine des Organismus dar. Sie 
sind die strukturgebenden Proteine von Haut, Knochen und Sehnen. Während der 
Synthese des Kollagens findet eine post-translationale Modifizierung des 
Prokollagens durch Proteasen statt, die die Propeptide abspalten. Durch das Fehlen 
der Propeptide sind Kollagenmoleküle in der Lage, sich zu langen Fibrillen 
aneinanderzulagern und es kommt zur Kollagenassemblierung. Im Rahmen dieser 
Dissertation konnte ich zeigen, dass die Metalloproteasen Meprin α und Meprin β die 
bisher einzigen bekannten Enzyme sind, die in der Lage sind, sowohl das C- als 
auch das N-Propeptid vom Prokollagen I in vitro und in vivo abzuspalten. Diese 
enzymatische Spaltung geht mit der Fibrillenbildung einher, die im 
Elektronenmikroskop beobachtet werden konnte. Konsequenterweise zeigen 
Meprin α und Meprin β Knockout-Mäuse signifikante Defekte bei der Integrität des 
Bindegewebes. Durch das Fehlen der C- und N-Proteinaseaktivität in Meprin 
Knockout-Mäusen kann weniger reifes Kollagen gebildet werden als in wildtypischen 
Kontrollmäusen. Histologische Untersuchungen der Haut haben ergeben, dass die 
Kollagenschicht dieser Meprin Knockout-Mäuse signifikant vermindert ist und die 
Kollagenfasern in der Haut dieser Mäuse weniger dicht gepackt, ungeordnet und 
kleiner im Durchmesser sind, woraus eine stark reduzierte Reißfestigkeit der Haut 
resultiert. Um das Fehlen der Prokollagen-Proteinaseaktivität zu kompensieren, 
werden die für das bone morphogenetic protein-1/mammalian tolloid (BMP-1/mTLD) 
codierenden Gene in diesen Mäusen stark überexpremiert.  
In der vorliegenden Arbeit zeige ich, dass sowohl Meprin α als auch Meprin β die 
Kollagenassemblierung in vitro und in vivo induzieren und somit an der Stabilität des 
Bindegewebes beteiligt sind. Sie regulieren die Kollageneinlagerung in der Haut und 
sind aus diesem Grund vielversprechende therapeutische Targets in der Fibrose. 
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1 Introduction 
Proteases are essential enzymes in almost all biological processes in health 
and disease, irreversibly modulating the proteome. The controlled regulation of 
proteolysis is crucial for the maintenance of tissue homeostasis and physiological 
balance. In humans, 578 proteolytic enzymes are encoded by about 2% of all genes 
[1,2]. The precise physiological function of the majority of these enzymes remains 
unknown.  
1.1 Meprin metalloproteases 
The metalloproteases meprin α and meprin β were discovered over 30 years 
ago, but little was known about their biological activity until recently. Meprins belong 
to the astacin family of metalloproteases, comprising only six members in humans. 
This family is characterized by a conserved zinc-binding motif 
(HExxHxxGxxHxxxRxDR) and the so called Met-turn in close proximity to the active 
site that includes a tyrosine residue as a fifth zinc ligand [3,4]. Meprin α and meprin β 
are expresses as highly glycosylated disulfide linked homo-dimers that require 
enzymatic removal of the N-terminal propeptide by serine proteases to gain full 
activity [3,5,6,7,8]. Meprins exhibit unique domain compositions among astacins 
comprising a N-terminal signal peptide directing the polypeptide chain to the 
endoplasmic reticulum, followed by a N-terminal propeptide, an astacin-like protease 
domain, a MAM (meprin A5 protein tyrosine phosphatase μ) and a TRAF (tumour-
necrosis-factor-receptor-associated factor) domain, both of which are known to 
mediate protein–protein interactions, an EGF (epidermal growth factor)-like domain, a 
transmembrane domain, and a C-terminal cytosolic tail (Fig. 1A) [3]. In contrast to 
meprin β, meprin α contains an additional “inserted” domain, which includes a furin 
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cleavage site. The cleavage by furin results in the loss of the EGF-like, 
transmembrane and cytosolic domains, and in a subsequent release of the soluble 
enzyme into the extracellular space where it further oligomerizes non-covalently, 
building huge complexes in the mega-Dalton range [3,6,9]. This makes meprin α the 
largest secreted protease known to date. Lacking the “inserted” domain, meprin β 
remains tethered to the cell membrane as a dimeric type I integral protein, but it can 
be released from the cell surface by ADAM10 and ADAM17 [3,10,11].  
 
Figure 1: Oligomeric structure of human meprin metalloproteases [3]. 
(A) Meprin α and meprin β are multi-domain enzymes, expressed as zymogens with a N-terminal 
propeptide (PRO) that must be removed proteolytically to gain full activity, followed by the protease 
domain (CAT). Meprins build dimers linked by one intermolecular disulfide bond between the MAM 
domains. Only meprin α contains an inserted domain (I) which is cleaved by furin during the secretory 
pathway. This results in secretion of soluble meprin α which further oligomerizes to large non-
covalently linked complexes, as visualized by electron microscopy of the purified recombinant enzyme. 
Meprin β predominantly remains membrane-bound, but it can be shed from the cell surface by 
ADAM10 and ADAM17. [3]. (B) Model of the membrane-bound form of meprin β and its orientation at 
the cell surface. EGF-like, transmembrane and cytosolic domains are displayed in grey, and 
phosphorylation sites are in yellow. Positively charged residues within the active-site cleft of the 
catalytic domain are shown in dark blue [3]. 
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The recently solved crystal structure of meprin β (Fig. 1B) suggests possible 
mechanisms of activation, substrate recognition and binding [12]. This knowledge is 
fundamental especially for the design of specific inhibitors however the structure 
does not reveal the physiological function of a protease.  
1.2 The meprin degradome 
In recent years new technologies have been employed to investigate the role of 
meprins in a physiological and pathological context. The central challenge for the 
characterization of a protease function is the identification of its substrate repertoire. 
Meprins have been implicated in angiogenesis, cancer, and inflammation [3]. 
However, it has not been completely understood which meprin mediated proteolytic 
events were responsible for these effects. Initially, the application of proteomics 
techniques allowed the characterization of the meprin degradome in a cellular 
context. Using the mass spectrometry based proteomics technique TAILS (terminal 
affinity isotope labeling of substrates) [13], which enables a direct identification of 
neo-N-termini generated by proteolysis, more than 100 extracellular proteins were 
identified as substrates of meprin α and meprin β consisting of growth factors, 
receptors, hormones, proteases, inhibitors and other proteins (Fig. 2) [10].  
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Figure 2: Categorization of meprin substrates identified using TAILS. 
Employing TAILS in the human cell lines HEK293, U373, HaCaT and CaCo-2 novel substrates were 
identified including inhibitors, receptors, proteases and other proteins with uncharacterized functions. 
Numbers of identified substrates are given in parentheses [10]. 
 
The amyloid precursor protein (APP) was identified by TAILS as a putative 
substrate for meprin β and Bien et al. confirmed that meprin β sheds APP from the 
cell surface, releasing Aβ peptides similarly to the known β-site APP-cleaving 
enzyme 1 (BACE-1) [14]. These Aβ peptides accumulated in amyloid plaques are 
neurotoxic and were proposed to have a pathological effect on the progression of 
Alzheimer’s Disease (AD) [3,15]. Additionally, meprin β cleaves the N-terminus of 
APP in vivo releasing N-terminal fragments of 22 and 11 kDa (APP22 and APP11) 
[16]. The latter was previously observed in human brain lysates [17] suggesting the 
physiological relevance of meprin β in neurobiology. On the other hand, using TAILS 
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it was possible to identify the α-secretase ADAM10 as a substrate for meprin β [10]. It 
has been shown that meprin β activates the α-secretase ADAM10 through cleavage 
of the propeptide. This leads to the activation of ADAM10 which is than able to shed 
APP by cleaving within the Aβ region, liberating the soluble ectodomain sAPPα, thus 
preventing the formation and aggregation of neurotoxic Aβ peptides (Fig. 3) [18,19]. 
Additionally, when active ADAM10 is able to shed the membrane bound meprin β 
from the cell surface, thereby releasing it into the extracellular space where it can 
cleave other soluble substrates. Therefore, the unbiased proteomics approach TAILS 
enabled to discover a possible proteolytic web of meprin β in a pathological context 
(Fig. 3). The network of interactions depends on the activities of proteases, their 
substrates and inhibitors [20]. Meprins themselves are expressed as zymogens and 
the enzymatic cleavage of the N-terminal propeptide by serine proteases leads to 
their activation. Interestingly, a range of serine protease inhibitors such as elafin, 
secretory leukocyte protease inhibitor (SLPI), and Lympho-epithelial Kazal-type-
related inhibitor (LEKTI) were found to be cleaved by meprins, increasing the 
complexity of the proteolytic web (Fig. 3) [10]. 
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Figure 3: Meprin β within the proteolytic web. 
Membrane-bound meprin β generates Aβ peptides which can form neurotoxic Aβ plaques [14]. On the 
other hand meprin β interacts with ADAM10, the constitutive α-secretase [10]. Shedding by ADAM10 
leads to soluble meprin β, which is no longer capable of cleaving at the β-secretase site, but still 
releases N-APP fragments that exhibit no neurotoxic capacity and are rather protective against death 
receptor 6 (DR6)-mediated neuronal death [16]. Human tissue KLKs are activators of meprin β [5] and 
their activity is regulated through the serine protease inhibitors elafin, SLPI and LEKTI, which can also 
be cleaved by meprin β [10]. 
 
1.3 The proteolytic web in skin 
The complexity of the proteolytic network becomes even more apparent in skin, 
where meprin α and meprin β are differentially expressed. The skin is the largest 
organ of the body, representing a barrier against external physical, chemical and 
biological influences due to its complex organization in distinct layers [3,21]. Both 
meprins are constitutively expressed in human epidermis [22]. Due to their different 
roles in keratinocyte differentiation meprin α and meprin β are expressed in different 
layers where they modulate the extracellular matrix (ECM), thereby contributing to 
the homeostasis in skin. The extracellular matrix plays an essential role in organizing 
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tissues, defining their shapes or in presenting growth factors. Meprin α is exclusively 
expressed in the stratum basale, where it might be activated by plasmin [7] and 
where it promotes proliferation of human keratinocytes. A range of growth factors, 
hormones, proteases and inhibitors were identified in human keratinocytes using 
TAILS as possible substrates for meprin α [10]. Additionally, in vitro studies 
demonstrated the processing of several components of the basal membrane such as 
collagen IV, fibronectin, laminin and nidogen by meprin α, thus contributing to the 
ECM remodeling during cell proliferation and migration [10,23,24].  
In contrast to meprin α, meprin β is expressed in the upper layer of the 
epidermis, the stratum granulosum, where it can be activated by KLK (kallikrein 
related peptidases) 4, 5 and 8 [5,22]. Upon activation, meprin β is able to cleave cell-
adhesion molecules such as E-cadherin and desmogleins thereby inducing terminal 
differentiation and might be involved in cornification and desquamation [10,25]. 
Additionally, Ohler et al. demonstrated the ability of meprin β to process proKLK7 
only two amino acids N-terminal from the activation site, subsequently leading to an 
enhanced activation of proKLK7 [5]. On the other hand, meprin β cleaves a range of 
serine protease inhibitors which directly modulate KLK activity (Fig. 3) [10]. This 
proteolytic web in the epidermis is further completed by the ability of meprin β to 
activate ADAM10, an enzyme known to be essential for epidermal homoeostasis 
[26]. The maintenance of the epidermal homeostasis is fundamental for the barrier 
function of the skin and dysregulation is often associated with pathological 
consequences as in the diseases psoriasis vulgaris and the Netherton syndrome.  
 
Introduction  18 
1.4 The role of meprins in collagen assembly 
The basal keratinocyte layer of the epidermis is attached to a basement 
membrane, which overlies the connective tissue layer known as the dermis. Dermal 
ECM consists of fibrillar collagens type I and III which are the main sources of 
mechanical strength and stability of the skin. The remodeling of the ECM is an 
important process in the homeostasis of connective tissue and combines synthesis, 
deposition, and degradation of ECM molecules [27]. Fibrillar collagens such as types 
I, II, and III are secreted as precursor molecules, the procollagens, and undergo a 
range of post-translational modifications upon the collagen fibril is built and deposited 
in the ECM. The key step in the formation of collagen fibrils is the proteolytic removal 
of the globular N- and C-terminal propeptides, thereby exposing short non-helical 
telopeptides at both the N- and the C-termini [28,29,30,31]. Consequently, these 
mature collagen molecules spontaneously assemble into collagen fibrils while the 
telopeptides are covalently cross-linked stabilizing the mature collagen fibrillar 
structure (Fig. 4) [29]. The N-propeptide of procollagen I is cleaved off by the 
members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin 
motifs) family, ADAMTS-2, -3 and -14, while the procollagen I C-proteinase activity is 
due to BMP-1 (bone morphogenetic protein-1) and related tolloid-like proteinases 
[32,33,34,35]. However, ADAMTS or BMP-1 knockout mice exhibit residual 
procollagen I N- or C-proteinase activity and are able to deposit collagen fibrils in skin 
[32,36]. This indicates that there are additional proteases which mediate cleavage in 
vivo.  
It has been shown that both, meprin α and meprin β cleave off the C-
propeptides from the fibrillar procollagen III in vitro at exactly the same site and even 
more efficiently than the procollagen C-proteinase BMP-1 [37]. Additionally, 
proteomic analyses using TAILS in a cell culture system revealed cleavage in 
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procollagen α2(I) by both meprin α and meprin β [10]. This cleavage would lead to 
the removal of the C-propeptide of the α2 chain of type I procollagen and induce 
collagen fibril formation. The removal of the C-propeptide from fibrillar collagens is 
the initial step in collagen fibril assembly, suggesting that meprins are involved in 
procollagen turnover and might contribute to collagen deposition in skin. This was 
further supported by the fact that both meprins are overexpressed in human dermal 
fibroblasts of fibrotic tumors (keloids) [37] where collagen synthesis, maturation and 
deposition take place.  
 
Figure 4: Procollagen I maturation and fibril formation. 
Fibrillar collagens secreted as procollagens containing a central triple helical domain, flanked by lineal 
N- and C-telopeptides (N-telo, C-telo), and globular N- and C-propeptides (NP, CP). Collagen fibril 
formation is induced by the proteolytic removal of the propeptides by members of the ADAMTS (a 
disintegrin and metalloproteinase with thrombospondin motifs) family, ADAMTS-2, -3 and -14 and 
BMP-1 (bone morphogenetic protein-1). The release of the mature collagen molecules leads to the 
spontaneous assembly into collagen fibrils while the telopeptides are covalently cross-linked stabilizing 
the fibrillar structure. 
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1.5 Meprins as therapeutic targets 
The implication of meprins in many pathological processes such as 
neurodegeneration, inflammation, cancer and fibrosis provides evidence that these 
enzymes might be promising therapeutic targets [3]. Initially the application of the 
proteomics approach PICS (proteomic identification of protease cleavage sites) 
contributed to the understanding of the cleavage specificity of meprin α and meprin β. 
Becker-Pauly et al. demonstrated the striking preference for negatively charged 
amino acid residues in the P1’ position for meprin α and meprin β [38]. This cleavage 
specificity was concordant with many cleavage sites generated by meprins in vitro 
and in vivo. According to the crystal structure of meprin β, negatively charged amino 
acid residues exhibit the ideal distribution for the interaction with the positively 
charged arginine residues Arg516 and Arg567, both part of the TRAF domain of meprin 
β and extended into the active site cleft [3,12]. This knowledge might be beneficial for 
the development of specific peptide-inhibitors as small inhibitory compounds for the 
regulation of meprin activity in pathological conditions as fibrosis.  
This study demonstrates that meprin α and meprin β are the first known C- and 
N-proteinases for type I procollagen in vitro and in vivo. Consequently, meprin α and 
meprin β knockout mice exhibit a reduced collagen I maturation and deposition in 
skin resulting in a decreased tensile strength of the skin. Since meprins are 
overexpressed in the dermis of human fibrotic skin, it is evident that the regulation of 
meprin activity in this pathologic condition might allow for the generation of a novel 
therapeutic approach to limit collagen deposition in skin.  
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2 Material and Methods 
2.1 Cleavage of human procollagen I heterotrimer by meprin α, meprin β, and 
BMP-1/PCPE-1 
Recombinant human meprin α and meprin β were expressed in baculovirus infected 
insect cells and purified and activated as described [6,22]. Full length human BMP-1, 
recombinant human PCPE-1 (procollagen C-proteinase enhancer-1), and 
recombinant human procollagen I heterotrimer were kindly provided by David Hulmes 
and Catherine Moali (Tissue Biology and Therapeutic Engineering Unit, CNRS, 
University of Lyon, France). 40 nM human procollagen I heterotrimer was incubated 
with 0.3 nM recombinant proteinase, in a total volume of 50 µl, for 1, 10, 30, 60 or 90 
min at 37°C, in reaction buffer (20 mM HEPES, pH 7.4 for meprin α and meprin β and 
50 mM Tris pH 7.4, 150 mM NaCl, 5 mM CaCl2, 0.02% Brij35 for BMP-1/PCPE-1). In 
the case of BMP-1, PCPE-1 was present at equimolar concentrations with respect to 
the substrate. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) under reducing conditions and transferred onto PVDF-
membranes by electroblotting. For immunodetection specific polyclonal antibodies 
raised against epitopes within the procollagen α1(I) (N-propeptide (LF-39), the C-
propeptide (LF-41), and the C-telopeptide (LF-68) [39], kind gift from Larry W. Fisher 
(National Institute of Health/NIDCR, Bethesda, USA) were used.  
Mass spectrometry based identification of meprin cleavage sites in human 
procollagen α1(I) and α2(I) was performed by the Z2 Unit of the CRC875 as 
described in [40].  
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2.2 De novo fibril formation assay using procollagen I heterotrimers 
For transmission electron microscopy, 0.1 mg/ml recombinant procollagen was 
incubated with 15 nM recombinant proteinase for 60 min at 37°C in reaction buffer 
(20 mM HEPES, pH 7.4 for meprin α and meprin β and 50 mM Tris pH 7.4, 150 mM 
NaCl, 5 mM CaCl2, and 0.02% Brij35 for BMP-1/PCPE-1). Staining of the samples 
and transmission electron microscopy was performed by Philipp Arnold ( Institute of 
Zoology, Johannes Gutenberg-University, Mainz, Germany) as described in [40]. 
2.3 Experimental animals and determination of the genotype 
12 to 16 week old male mice on a congenic C57BL/6 background were used for this 
study. Three genotypes were studied, wild-type (WT) mice and meprin α and meprin 
β knockout mice in which the meprin genes were ablated [41]. Mice were maintained 
on a 12-hour light–dark cycle, with food and water ad libitum. Genotype of the mice 
was determined by PCR. Tail biopsies were incubated overnight at 55°C with gentile 
agitation in 200 μl Direct PCR Lysis Buffer (PEQLAB Biotechnology GmbH) with 
proteinase K added to 0.1 mg/ml final concentration. Proteinase K was heat 
inactivated at 85°C for 45 minutes, samples were stirred and DNA was then used for 
PCR analyses to determine the genotype (Tab. 1). PCR primers (Invitrogen) were 
used to amplify the neomycin cassette containing the stop codon [41] as well as the 
whole modified exon 7 of Mep1a or Mep1b gene. Amplified DNA was separated on a 
0.8% agarose gel. PCR primers mepa18-forward and mepa9-reverse generated 
3.1 kb big fragments amplifying the WT exon 7 of the Mep1a gene and 4.3 kb big 
fragments, when the neomycin cassette was inserted. Using the primer mepb9Ge2-
forward and mepb8Ge2-reverse, which flank the exon 7 of the Mep1b gene, PCR 
products were 2.36 kb in size when exon 7 was not modified and 3.96 kb when exon 
7 contained the neomycin cassette. Since the signal for the modified exon was very 
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weak in Mep1b+/- and Mep1b-/- samples, additionally PCR primers flanking only the 
131 bp long neomycin cassette (neo-forward and neo-reverse) were used to confirm 
the genotype (Tab. 1).  
 
Table 1: PCR Primers used for determination of the genotype of mice. 
Primer Sequence 
mepa18-forward 5’-GCG AGG GAC CTC CCA TGA TAA ACT TAG G-3’ 
mepa9-reverse 5’-CCC CTG GAG TCT GTC TAG TAG CCA TCA TC-3’ 
mepb9Ge2-forward 5’-GCC TTG GTC GTC CG GAGA AGC TAA CTA CTC-3’ 
mepb8Ge2-reverse 5’-ACC AGG CTA CTT AGC TCC CTG TTA TTG-3’ 
neo-forward 5’-TCA AGG GCA GTG GGT GCT GGT 3’ 
neo-reverse 5’-ATG CCA GAA TCC CAG GGC GTG-3’ 
 
 
Table 2: Pipetting scheme for genotyping PCR. 
Reagent Volume for Mep1a-PCR Volume for Mep1b-PCR 
DNA Template 2 μl 1 μl 
10 x Taq Polymerase Buffer  5 μl 3 μl 
dNTP Mix (2mM) 5 μl 1 μl 
forward primer (10 μM) 1 μl 0.3 μl 
reverse primer (10 μM) 1 μl 0.3 μl 
ddH2O add 50 μl add 30 μl  
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Program for Mep1a-PCR.  
Initial denaturation 95°C 2 min  
Denaturation 98°C 20 sec  
Annealing 60°C 30 sec 30 cycles  
Elongation 72°C 4.5 min  
Final elongation 72°C 4.5 min 
 
Program for Mep1b-PCR.  
Initial denaturation 95°C 2 min  
Denaturation 98°C 20 sec  
Annealing 64°C 30 sec 35 cycles  
Elongation 68°C 6 min  
Final elongation 68°C 6 min 
 
2.4 Skin lysate preparation 
Dorsal skin was shaved, dissected and pulverized into powder in a liquid nitrogen-
cooled pestle and mortar. Skin lysates were prepared by adding lysis buffer (50 mM 
Tris/HCl, pH 6.8, 150 mM NaCl, 1% TritonX100, 1% SDS, 2 mM EDTA) containing a 
cocktail of CompleteTM protease inhibitors (Roche Applied Science) for 24 h at 4°C. 
Skin homogenates were then centrifuged at 13,000 rpm at 4°C for 30 min. The 
supernatant was used for Western blot analysis as described in 2.1. Since the anti-N-
propeptide antibody (LF-39) did not cross-react with murine procollagen I it was not 
used for detection of collagen in murine skin lysates. Western blots were quantified 
by using ImageJ 1.47 [40]. 
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2.5 Histological analyses 
Biopsies from dorsal skin of WT (n=6), Mep1a-/- (n=6), and Mep1b-/- (n=6) mice were 
fixed 24-48 h in neutral buffered formalin (4%). Paraffin embedding and azan 
trichrome staining was performed by Kerstin Bahr (Institute of Anatomy, University 
Medical Center of the Johannes Gutenberg-University, Mainz, Germany) as 
described in [40]. The thickness of the collagen layer was measured by light 
microscopy (Axiophot, Zeiss) using the morphometry software Diskus 4.8 (Hilgers). 
The mean thickness of the different specimens was obtained taking the average of 
five measurements per section [40]. 
2.6 Tissue preparation for transmission electron microscopy of dermal fibrils 
Skin samples from age-matched wild-type, Mep1a-/-, and Mep1b-/- animals were fixed 
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer pH 7.5 with 0.1 M sucrose, 
followed by post-fixation with 2% osmium tetroxide. After dehydration in a graded 
series of ethanol solutions (30, 50, 70, 80, 90, 95, and 100%) samples were 
embedded in Araldite. Ultrathin sections (50 nm) (Ultracut S Microtome, Leica, 
Microsystems) were visualized using a Tecnai12 (FEI) electron microscope operating 
a LaB6 electron source. Images were taken by Philipp Arnold (Institute of Zoology, 
Johannes Gutenberg-University, Mainz, Germany) on a 4kx4k CCD camera (TVIPS). 
Average diameters (nm) were obtained by measuring fibrils from 3 WT (n=414), 3 
Mep1a-/- (n=598), and 3 Mep1b-/- mice (n=414). Graphs were plotted using the 
software package R 2.13.0 [40]. 
2.7 Biomechanical testing of maximum skin tensile strength 
Dorsal skin from wild-type (n=6) and aged-matched meprin α (n=6) and meprin β 
(n=6) knockout mice was carefully shaved; dissected, and pinned to avoid shrinking. 
All biopsies tested (3-4 per mouse and strain) had a defined hourglass form with a 
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width of 3 mm at the narrowest part, constituting a predefined breaking point. All skin 
specimens were orientated parallel to the spine and were kept moist with 0.9% 
isotone NaCl at room temperature. Specimens were held between the gripping jaws 
and were stretched at a constant rate of 3 mm/s, which resulted in load onset rates of 
less than 0.05 N/s. The end point was the ultimate load (in Newton, N) at which skin 
disruption occurred. A position encoder (WA300) was used to register the distance 
covered, and a force transducer for traction and compression (S2, maximum value 
500 N) was used to quantify the power impacting on the skin. The resulting values 
were recorded by a multiple channel PC measuring device (Spider 8) and plotted as 
a distance-power curve (software, Catman 3.0; both from HBM Hottinger Baldwin 
Messtechnik). The mean maximum tensile strength for each mouse was obtained by 
averaging three to four measurements per animal [40]. 
2.8 RNA isolation, reverse transcription and quantitative real-time PCR 
Total RNA was isolated from skin and primary fibroblasts of WT, meprin α, and 
meprin β knockout animals (n=3) using the GeneJET RNA Purification Kit 
(Fermentas, Thermo Scientific). Equal amounts of RNA (1 µg) were transcribed into 
complementary DNA in 25 µl reaction mixtures using RevertAid™ Transcriptase 
(200 U/ml), 10 mM nonspecific oligo d(T) primers, and 200 mM dNTPs (Fermentas, 
Thermo Scientific). The cDNA obtained was subjected to quantitative real-time PCR 
measurement in a 10 μl reaction, using the LightCycler480® Real-Time PCR System 
(Roche Applied Science) according to the manufacturer’s instructions. The 
amplification reaction consisted of a hold of 10 min at 95°C then 45 cycles 
(10 sec/95°C, 30 sec/60°C). For assay design, the Universal ProbeLibrary System 
(http://qpcr.probefinder.com/roche3.html) was used to amplify intron spanning 
regions for the gene of interest. Relative amounts of target gene mRNA were 
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normalized to the housekeeping gene GAPDH (Glyceraldehyde-3-phosphate 
dehydrogenase). The following primers and probes were used: 
 
Table 3: Primers and corresponding probes for quantitative real time PCR using the 
LightCycler480® Real-Time PCR System.  
Primer Sequence Probe 
BMP-1/mTLD_forward 5’-GCA CTA TGC CCG GAA CAC-3’ 
# 80 
BMP-1/mTLD_reverse 5’-CCT CAT ACT TGG GAA CAA TGG-3’ 
mTLL-1_forward 5’-AAA GAG TGC ACG TGG GTG AT-3’ 
# 72 
mTLL-1_reverse 5’-AAC CTC AAA CTC ATT GAA GGC TA-3’ 
mTLL-2_forward 5’-CAT GAG AAC GGA CAC GAC TG-3’ 
# 71 
mTLL-2_reverse 5’-CCT CTG CAC TGC TGA TCT TG-3’ 
 
For analysis of connective tissue associated genes a mouse fibrosis PCR array was 
used according to the manufacturer’s instructions (SA Biosciences). ΔΔCp values 
were used to calculate the relative expression for each data point [40]. 
2.9 Collagenase activity of human recombinant MMP-1 in vitro 
Human recombinant MMP-1 was a kind gift from Christopher Overall, UBC 
Vancouver, Canada [42]. 40 ng human recombinant pro-MMP-1 were activated with 
1 mM p-aminophenylmercuric acetate (APMA) for 2 h at 37°C prior to or after 
incubation with 4.5 nM meprin α or meprin β. All activity assays were performed in 
50 mM HEPES, pH 7.5 with 10 μM quenched fluorogenic peptide Mca-Pro-Leu-Gly-
Leu-A2(Dnp)-Ala-Arg-NH2 at 37°C and the fluorescence was detected over 120 min. 
Enzyme activity was measured with the fluorescent spectrometer Varioskan Flash 
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(Thermo Scientific) and data were analyzed using “SkanIt Software 2.4 for Varioskan 
Flash”. Proteolytic activity was calculated from the emission at 405 nm with an 
excitation at 320 nm [40].  
2.10 Cleavage of recombinant human Hsp47 by meprin α and meprin β in vitro.  
Human recombinant Hsp47 (heat shock protein 47), was kindly provided by Ulrich 
Baumann and Jan Gebauer (Institute of Biochemistry, University of Cologne, 
Germany). 5 μg human recombinant Hsp47 was incubated with 15 nM meprin α or 
meprin β, in a total volume of 10 µl for 1, 30, and 60 minutes at 37°C, in 20 mM 
HEPES buffer at pH 7.5, 7.0, 6.5 or 6.0. SDS-PAGE was performed under reducing 
conditions and subsequently stained with Coomassie solution. Collagen binding 
ELISA was performed by Jan Gebauer as described in [43]. 
2.11 In vitro activity of meprin α, meprin β and BMP-1 
All activity assays were performed with 15 nM protease in 20 mM HEPES buffer, pH 
7.5 with 10 μM quenched fluorogenic peptide (Genosphere Biotechnologies) at 37°C 
and the fluorescence was detected until protease saturation. All assays were 
performed in duplicates in a 96-well plate in a total volume of 100 μl. Fluorogenic 
peptides used for this study are listed in table 4. Enzyme activity was measured with 
the fluorescent spectrometer Infinite 200 PRO (TECAN) and data were analyzed 
using Magelan software version 7.1. Proteolytic activity was calculated from the 
emission at 405 nm with an excitation at 320 nm.  
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Table 4: Quenched fluorogenic peptides for determination of meprin β activity. 
Substrate Sequence 
P1 Mca-Glu-Asp-Glu-Asp Glu-Asp-(Dnp) 
P2 Mca-Glu-Glu-Glu-Glu-Glu-Glu-(Dnp) 
P3 Mca-Asp-Asp-Asp-Asp-Asp-Asp-(Dnp) 
P4 Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys-(Dnp) 
 
Inhibition studies with the phosphinic meprin β inhibitor (PMI) (kind gift from Vincent 
Dive, CEA, Service d’Ingénierie Moléculaire des Protéines, Cedex, France) were 
performed with 1 nM meprin β in 20 mM HEPES buffer, pH 7.5 with 10 μM quenched 
fluorogenic substrate P4 (Tab. 4). 1-100 nM phosphinic meprin β inhibitor was 
incubated with active meprin β for 30 min at 37°C subsequently enzyme activity was 
measured.  
2.12 Cell surface activity of meprin β 
Equal amount of MDCK (Madin-Darby Canine Kidney Epithelial) cells stably 
transfected with wild-type human meprin β or the meprin β catalytically inactive 
mutant E90A was seeded in a 24-well plate and were grown in DMEM with 10% FCS 
until 90% confluence. Cell culture medium was removed and cells were rinsed once 
with PBS to remove traces of FCS. Cell surface activity of meprin β was determined 
in the presence or absence of 100 nM phosphinic meprin β inhibitor and 10 μM 
quenched fluorogenic peptide P1 (Tab. 4) in a total volume of 400 μl in FCS-free 
DMEM. Enzyme activity was calculated as described in 2.11. 
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2.13 Meprin β activity in kidney lysates 
Kidneys from WT, Mep1b-/+, and Mep1b-/- mice were pulverized into powder in a 
liquid nitrogen-cooled pestle and mortar. Kidney lysates were prepared by adding 
lysis buffer (1% TritonX100 in PBS, pH 7.4) containing a cocktail of CompleteTM 
protease inhibitors without EDTA (Roche Applied Science) for 30 min on ice. Kidney 
homogenates were then centrifuged at 13,000 rpm at 4°C for 30 min. The 
supernatant was used for determination of meprin β activity. Protein concentrations 
were determined using the BCA (bicinchoninic acid) assay (Fermentas, Thermo 
Scientific) with bovine serum albumin as standard. Meprin β activity was measured in 
200 μg total protein in the presence or absence of 100 nM phosphinic meprin β 
inhibitor or 10 μM actinonin and 10 μM quenched fluorogenic peptide P1 (Tab. 4) as 
described in 2.11. 
2.14 In vitro activity of KLK2, KLK4, and KLK7 and determination of IC50 
Recombinant human kallikrein-related peptidases (KLK) 2, 4 and 7 were a kind gift 
from Viktor Magdolen (Clinical Research Unit, Department of Obstetrics and 
Gynecology, Technical University of Munich, Germany). For all activity 
measurements 50 μg/ml protease (KLK2, KLK4, and KLK7) were used in 50 mM 
Tris/HCl buffer, pH 8.0, containing 100 mM NaCl and 0.005% Tween 20. All activity 
assays were performed in duplicates in a 96-well plate in a total volume of 100 μl. 
Activity of KLK2 and KLK4 was determined using the quenched fluorogenic peptide 
Z-Pyr-Gly-Arg-Mca (Peptide Institute Inc.). For KLK7 activity measurements the 
quenched fluorogenic peptide Suc-Leu-Leu-Val-Tyr-AMC (Peptide Institute Inc.) was 
applied. Rate of hydrolysis was monitored as described in 2.11.  
For determination of the IC50 values of recombinant human sAPP751, proteases were 
incubated for 10 min at 37°C with sAPP751 (1 nM, 10 nM, 40 nM, 60 nM, 80 nM and 
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100 nM). Following addition of the appropriate substrate (60 μM Z-Pyr-Gly-Arg-Mca 
or 30 μM Suc-Leu-Leu-Val-Tyr-AMC), the rate of proteolysis was monitored as described 
in 2.11. IC50 was calculated by nonlinear regression analysis using the GraFit 
software version 4.0.  
2.15 Generation of monoclonal antibodies against human meprin α 
Generation of hybridoma-producing monoclonal antibodies (mAb) against human 
meprin α, purification and biotin labeling of the antibodies was performed by Achmad 
Trad (Z2 Unit of CRC875) as described in [44]. 
To investigate the specificity of the generated mAb, Western blot analyses were 
performed using 0.5 μg recombinant human proteases. Binding of mAb to native 
meprin α was analyzed by immunoprecipitation. 200 μl of cell culture medium from 
human colon carcinoma cell line CaCo-2 were incubated with 200 μl hybridoma 
medium containing mAb over night at 4°C. 50 µl Protein G Agarose-beads 
(Fermentas, Thermo Scientific) were added to precipitate the soluble meprin α. After 
final washing steps beads were heated in 3x sample loading buffer to elute 
immunoprecipitated proteins, which were then loaded on 10% SDS-gels. Proteins 
were separated by SDS-PAGE, and subsequently transferred on a PVDF membrane. 
PVDF membrane was blocked in 3% BSA in TBS (10 mM Tris/HCl, pH 7.6, 150 mM 
NaCl) for 1 h and then incubated with supernatants containing the mAb diluted at 
1:100 in 3% BSA over night at 4°C. Blots were then incubated for 1 h with anti-mouse 
IgG POD conjugate. Protein bands were visualized by chemiluminescence using 
ECL.  
2.16 Establishing a meprin α specific sandwich ELISA 
For sandwich ELISA Microtiter plates (Nunc, Denmark) were coated with 10 µg/ml of 
purified antibody M41-14/M41-15 per well in coating buffer (0.5 M 
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carbonate/bicarbonate buffer, pH 9.6) and incubated over night at 4°C. Then, plates 
were washed using the washing solution (PBS, 0.1% BSA) and blocked with 1% BSA 
in PBS for 2 h at room temperature. 100 μl of human serum, cell culture medium or 
4-3000 ng/ml meprin α was added and incubated for 2 h at room temperature. Blank 
control was performed with PBS. The plates were washed with washing solution and 
the antigen was detected by 100 μl of biotinylated antibody M41-14/M41-15 at a final 
concentration of 1 µg/ml. The detection of biotin was performed by adding 100 μl of 
streptavidin-POD conjugate (Pierce) diluted 1:8000 in washing solution. After 
washing, the plate wells were incubated with 100 μl of BM blue POD substrate 
(Roche, Germany) in the dark at room temperature for 10 min. Then, the reaction 
was stopped by adding 50 μl of 0.8 M H2SO4. The optical density (OD) was 
measured at 450/540 nm on a plate reader (TECAN). 
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3 Results and Discussion 
Most of the data presented in this dissertation are published, and summarized herein. 
Unpublished data are described in detail. 
3.1 Role of meprin α and meprin β in collagen assembly in skin 
Application of the proteomic analyses TAILS in a cell culture system revealed 
cleavage in procollagen α2(I) by both meprin α and meprin β [10]. This cleavage 
would lead to the removal of the C-propeptide of the α2 chain of type I procollagen 
implicating the role of meprins in collagen fibril formation. Additionally, it has been 
shown recently that both, meprin α and meprin β cleave off the C-propeptides from 
fibrillar procollagen III in vitro at exactly the same site and even more efficient than 
the procollagen C-proteinase BMP-1 [37].  
To investigate the procollagen proteinase activity of meprin α and meprin β in 
vitro, human recombinant procollagen I heterotrimer consisting of two α1(I) and one 
α2(I) molecules was used as substrate (Fig. 5A). Procollagen was incubated with 
meprin α or meprin β for 1, 10, 30, and 90 minutes and processing was analyzed by 
Western blotting with specific antibodies raised against the procollagen α1(I) C-
propeptide, N-propeptide or C-telopeptide. As a control, procollagen I was also 
processed with recombinant BMP-1 in the presence of procollagen C-proteinase 
enhancer (PCPE) -1, which is known to stimulate BMP-1 proteinase activity on 
fibrillar procollagen [34]. As expected, BMP-1 generated pN-collagen by removing the 
C-propeptides but not the N-propeptides, corresponding to its PCP activity (Fig. 5B). 
Interestingly, in the presence of meprin α as well as of meprin β not only the C-
propeptides but also the N-propeptides were cleaved off from procollagen I, leading 
to the release of mature collagen I (Fig. 5B). Obviously, the maturation process of 
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procollagen I, induced by meprin β was more efficient compared to meprin α, 
resulting in full conversion of procollagen I already after 30 minutes. [40].  
 
 
Figure 5: Cleavage of type I procollagen by meprin α and meprin β. 
(A) Schematic of the type I procollagen molecule consisting of an N-terminal propeptide (NP I), the N-
telopeptide (N-telo), the triple helical region, the C-telopeptide (C-telo) and the C-terminal propeptide 
(CP I). (B) Cleavage of recombinant procollagen heterotrimer by BMP-1, meprin α, and meprin β after 
1, 10, 30, and 90 min. Processing analyzed by SDS-PAGE (10% w/v polyacrylamide) under reducing 
conditions followed by Western blotting using anti-collagen α1(I) C-propeptide antibody (anti-α1Cp), 
anti-collagen α1(I) N-propeptide antibody (anti-α1Np), and anti-collagen α1(I) C-telopeptide antibody 
(anti-α1Ct). Magic Mark XP (Invitrogen) was used as molecular weight marker. (D) Cleavage of 
procollagen I for proteomics analysis. Arrows indicate cleavage sites analyzed by proteomics for 
meprin α (α) and meprin β (β). Numbers display positions of amino acids in the full-length protein [40].  
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In order to identify the cleavage sites in procollagen I generated by meprin α or 
meprin β LC-MS based proteomics analyses were performed. Cleavage by meprin α 
and meprin β occurred at position Ala1218/Asp1219 in full-length procollagen α1(I) 
(Fig. 5C). Additionally, analyses of the released C-propeptides revealed cleavage at 
positions Arg1227/Asp1228 and Tyr1108/Asp1109 in the procollagen α1(I) and α2(I) 
chains, respectively (Fig. 5C). Further meprin α and meprin β cleavage sites in the N-
propeptides of the procollagen α1(I) and α2(I) chains were identified at positions 
Tyr166/Asp167 or Tyr81/Asp82, respectively (Fig. 5C) [40].  
The removal of the globular N- and C-propeptides is the key step in the 
formation of the collagen fibril. After enzymatic cleavage of the propeptides mature 
collagen monomers spontaneously assemble into collagen fibrils with the 
characteristic D-banding pattern [45,46]. Although not all identified cleavage sites in 
procollagen I were identical with the known cleavage sites for BMP-1 and ADAMTS-
2, de novo collagen fibril formation visualized by electron microscopy could be 
observed only in the presence of meprin α or meprin β. As expected, BMP-1 was not 
able to trigger self-assembly of collagen fibrils, as this protease removed the C-
propeptides but not the N-propeptides of procollagen I (Fig. 5, 6). In contrast, meprin 
α and meprin β induced self-assembly of collagen fibrils, consistent with their 
procollagen C- and N-proteinase activity (Fig. 5B, 5C). Particularly meprin β was able 
to trigger the characteristic D-banding pattern, due to its more efficient removal of the 
propeptides as deduced from Western blot analysis (Fig. 5B, 6A) [40]. Thus, meprin 
α and meprin β are the first known procollagen proteinases which are able to remove 
both the C- and the N-propeptides from procollagen I thereby inducing collagen fibril 
formation in vitro. 
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Figure 6: De novo fibrillogenesis of type I collagen after cleavage by meprins. 
(A) Transmission electron micrographs of negatively stained collagen fibrils assembled after cleavage 
of recombinant procollagen type I heterotrimer by meprin α and meprin β after 60 min. As a control, 
untreated recombinant procollagen I was visualized. (B) Cartoon summarizes procollagen processing 
by different proteases and subsequent assembly of collagen fibrils [40]. 
 
 
In order to investigate whether meprin α and meprin β are procollagen 
proteinases in vivo, skin biopsies from wild-type, Mep1a–/–, and Mep1b–/– mice were 
analyzed by Western blotting using antibodies against the collagen α1(I) C-
propeptide or C-telopeptide. Since the anti-N-propeptide antibody did not cross-react 
with murine procollagen I it was not used for in vivo studies. Interestingly, both 
procollagen C- and N-proteinase activity were affected in the skin of meprin α and 
meprin β knockout mice (Fig. 7A, 7B). In skin lysates from meprin α and meprin β 
knockout mice, lower amounts of mature collagen I were observed and consequently, 
significantly reduced amounts of C-propeptides were detected in Mep1a−/− and 
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Mep1b−/− skin compared to the control, indicating diminished procollagen C- and N-
proteinase activity in vivo (Fig. 7B) [40].  
 
 
Figure 7: In vivo analysis of collagen I maturation in skin of WT, Mep1a–/–, and Mep1b–/– 
mice. 
Western blot analysis of skin lysates from WT, Mep1a
–/–
, and Mep1b
–/–
 mice (gels run in reducing 
conditions) using antibodies against the collagen α1(I) C-propeptide (anti-α1Cp) or C-telopeptide (anti-
α1Ct) with actin as control (anti-actin) demonstrate the proteolytic processing of procollagen I in vivo. 
Asterisk indicates cross-linked mature collagen I. Ctrl: 40 nM human procollagen I heterotrimer 
incubated with 0.3 nM meprin α in a total volume of 50 μl, for 10 min at 37°C. (B) Western blot 
analyses and quantification of cleaved C-propeptides in skin lysates from WT, Mep1a
–/–
, and Mep1b
–/–
 
mice using antibodies against the collagen α1(I) C-propeptide (anti-α1Cp) with tubulin as control (anti-
tubulin). Western blots from skin lysates from each of 5 WT, Mep1a
–/–
, and Mep1b
–/–
 mice were 
quantified by using ImageJ 1.47. (*p<0.05; **p<0.01) [40]. 
 
 
The maturation of procollagen and the arrangement of collagen fibrils are 
essential for the integrity and function of connective tissue. Due to the ability of both 
meprins to generate mature type I collagen as well as the decreased procollagen 
processing observed in the skin of meprin knockout mice, the morphology and 
deposition of collagen fibrils was analyzed in situ. Histological examination of dorsal 
skin from Mep1a-/- and Mep1b-/- mice exhibited a significantly reduced thickness of 
the fibrous layer and a decreased accumulation of dermal collagen compared to 
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control animals (Fig. 8A, 8C), reflecting the observation of the Western blot analysis 
(Fig. 7). While the dermal collagen layer in wild-type mice was approximately 400 μm 
in thickness, in age-matched Mep1a-/- and Mep1b-/- mice corresponding thicknesses 
were approximately 170 μm and 150 μm, respectively (Fig. 8C) [40]. In contrast to 
the dramatic differences in the fibrous layer of meprin knockout and wild-type mice, 
no obvious morphological abnormalities in the epidermis or in the shape and number 
of hair follicles was observed.  
Additionally, the arrangement of dermal collagen fibrils in meprin α and meprin 
β knockout mice was impaired compared to age-matched wild-type mice as 
visualized by transmission electron microscopy. While collagen fibrils in wild-type 
dermis displayed a compact and uniform arrangement the fibrils in Mep1a-/- and 
Mep1b-/- dermis were often irregularly organized, less tightly packed, and of smaller 
diameters compared to those in wild-type skin (Fig. 8B, 8D). A biomechanical 
approach revealed a significantly reduced maximum tensile strength of the skin of 
Mep1a-/- and Mep1b-/- mice compared to WT animals (Fig. 8E) in line with the 
reduced dermal collagen deposition (Fig. 8A) and the disordered organization of the 
collagen fibrils [40]. 
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Figure 8: In vivo analysis of collagen I deposition and mechanical strength in skin of 
WT, Mep1a–/–, and Mep1b–/– mice. 
(A) Azan-stained skin cross-sections for visualization of collagen deposition (red arrow) in the dermis 
of Mep1a
-/-
 and Mep1b
-/-
 mice compared to the skin of age-matched wild-type animals. Scale=200 μm. 
(B) Dermal collagen fibrils examined by transmission electron microscopy. Fibrils in Mep1a
-/-
 and 
Mep1b
-/-
 skin cross-sections display a less tightly packed organization (red arrows) while the WT 
collagen fibrils show the characteristic compact and uniform arrangement. Scale bar=1 μm. (C) 
Dermal collagen deposition was quantified by light microscopy. The mean thickness of the different 
biopsies was obtained by averaging five measurements per section (***p<0.001). (D) Box plot shows 
the average diameters (nm) for dermal collagen fibrils of Mep1a
-/-
, Mep1b
-/-
, and WT mice, obtained by 
measuring 414 fibrils from 3 WT mice, 598 fibrils form 3 Mep1a
-/-
 mice, and 414 fibrils from 3 Mep1b
-/-
 
mice. Bottom of the box indicates the 25
th
 percentile, top the 75
th
 percentile. The median values are 
shown as horizontal lines, indicating the 50
th
 percentile. Whiskers indicate the lowest datum still within 
1.5 interquartile range (IQR) of the lower quartile, and the highest datum still within 1.5 IQR of the 
upper quartile. Outliers are shown as open circles. (***p<0.001). (E) Determination of the maximum 
tensile strength of the skin of meprin α and meprin β knockout mice revealed a significant decrease 
(***p<0.001) compared to the skin of wild-type mice [40].  
 
 
For many years BMP-1/tolloid-like proteinases were the only known procollagen 
C-proteinases in vitro and in vivo. However, in mouse embryonic fibroblasts (MEF) 
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isolated from Bmp1-/-/Tll1-/- mice residual procollagen C-proteinase activity was 
present, indicating that other proteases contribute to the maturation of procollagen 
[36]. While Pappano et al. [36] suggested that mTLL-2 might fulfill such a role, this 
work provides evidence that meprin α and meprin β could be responsible for collagen 
I maturation in vivo. Interestingly, the collagen fibrils in BMP-1 deficient embryos are 
relatively thin in diameter and the arrangement of these fibrils is less organized 
compared to the wild-type control [47], which is similar to the observed phenotype in 
meprin α and meprin β knockout mice [40]. Recently it became obvious that astacins, 
including meprin α, meprin β, and tolloids, exhibit a unique family-wide cleavage 
specificity with negatively charged amino acid residues in P1’ [38]. Consequently, this 
suggests most known BMP-1 substrates, like fibrillar procollagens, being candidate 
target molecules for meprin α and meprin β as well. In this regard, it was 
demonstrated that both meprins process the C-propeptide of type III procollagen in 
vitro exactly at the same site but even more efficient as BMP-1 [37]. The results of 
this study clearly demonstrate the physiological relevance of of meprin α and 
meprin β to remove the C- as well as the N-propeptide of type I procollagen, 
subsequently releasing fibril forming mature collagen molecules. Besides the 
phenotype of Mep1a-/- and Mep1b-/- mice at the histological level, the observed 
reduced levels of procollagen I conversion in skin of meprin knockout mice provide 
further evidence that meprin α and meprin β exhibit procollagen C-proteinase activity 
in vivo [40].  
Previous publications demonstrated the requirement of ADAMTS-2 in the 
removal of the N-propeptide of type I collagen. Analogous to the procollagen C-
proteinase activity of BMP-1/tolloid-like proteinases, residual procollagen N-
proteinase activity was observed in ADAMTS-2 deficient mice [32]. It was proposed 
that ADAMTS-14 may carry out this activity, but this has not yet been demonstrated 
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in vivo. The present work shows, that both meprins cleave off the N-propeptides of 
type I procollagen in vitro. Additionally, reduced procollagen N-proteinase activity in 
skin of meprin knockout mice as well as the distinct phenotype provide strong 
evidence that the enzymatic activity of meprins is physiologically relevant for the 
removal of the N-propeptide in vivo. Most interestingly, identification of meprin 
cleavage sites by mass spectrometry revealed positions Tyr81/Asp82 in the α2 chain 
within an amino acid region which is known to cause Ehlers-Danlos syndrome VIIB 
when deleted by impaired splicing [40]. EDS VII is an inherited autosomal disorder, 
characterized either by an impaired splicing of exon 6, leading to the loss of the N-
proteinase cleavage site and surrounding residues in the Col1A1 or Col1A2 genes 
[48], or by deficient ADAMTS-2 activity [49,50]. These mutations result in reduced N-
terminal processing of procollagen I and subsequent disordered collagen assembly. 
In skin biopsies of patients with EDS VII, collagen fibrils are more loosely and 
randomly organized, and have smaller diameters compared to normal dermal 
collagen fibrils, similar to the phenotype observed in Mep1a-/- and Mep1b-/- mice 
[40,51]. Taken together, both meprins are involved in processing of fibrillar collagens 
thereby contributing to the mechanical integrity of the skin [40]. Reduced tensile 
strength observed in the skin of meprin α and meprin β knockout mice may result 
from the disorganized and thin collagen fibrils, and a diminished dermal collagen 
deposition as a product of decreased collagen maturation [40].  
Nevertheless, the fact that Mep1a-/- and Mep1b-/- mice are viable, although 
exhibiting ~50% reduced litters compared to WT mice [52] indicates that the loss of 
meprin is compensated. To investigate differential gene expression in the skin of 
Mep1a-/- and Mep1b-/- mice, a mouse PCR array was employed (Fig. 9A-D). 
Alterations in the expression of 84 genes associated with connective tissue formation 
were examined. Interestingly, expression of Col1a2 was about 2.5 fold increased in 
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Mep1a-/- but not Mep1b-/- mice, whereas Col3a1 was slightly decreased in the skin of 
meprin α and meprin β knockout animals (Fig. 9A, 9B). However, the overexpression 
of Col1a2 in Mep1a-/- mice did not compensate the reduced collagen deposition in 
skin of these mice. Fibrillar collagen degrading enzymes, including the interstitial and 
neutrophil collagenases Mmp1a, 2, 3, 8, 9, 13, and 14, showed a general tendency of 
decreased gene expression (Fig. 9A, 9C). The same was observed for Timp1 and 3 
(tissue inhibitors of metalloproteases), whereas Timp2 and 4 were significantly 
increased in Mep1a-/- but not Mep1b-/- mice (Fig. 9A, 9D) [40]. TIMP-3 is known to 
inhibit the N-proteinase ADAMTS-2 [53]. A decrease in Timp3 expression would 
consequently lead to an increase in procollagen N-proteinase activity of ADAMTS-2 
in meprin knockout mice. However, the regulation at the mRNA level is insufficient to 
compensate the loss of the N-proteinase activity of meprin in skin of meprin knockout 
mice, indicating once again the implication of meprins in procollagen processing in 
vivo.  
Since procollagen C-proteinase activity is associated with the BMP-1/tolloid-like 
proteinases, that is BMP-1 itself and its splice variant mammalian tolloid (mTLD), 
which were not included in the fibrosis PCR array, the expression of these enzymes 
was analyzed in the absence of meprin α or meprin β by quantitative real-time PCR. 
In Mep1a-/- and Mep1b-/- skin, and also in corresponding primary fibroblasts, the 
mRNA expression of BMP-1/mTLD was significantly increased compared to the wild-
type control (Fig. 9E, 9F). In the skin of knockout animals a 2-fold increase of BMP-
1/mTLD expression was observed, which was lower in the Mep1a-/- fibroblasts, but 
still significant. Although, BMP-1 and mTld are overexpressed in meprin deficient 
animals and may partially compensate the loss of procollagen C-proteinase activity, 
this is apparently insufficient to maintain the full conversion of procollagen into 
physiologically required amounts of fibril forming molecules [40].  
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Figure 9: Regulation of fibrosis relevant genes in skin of Mep1a-/- and Mep1b-/- mice. 
(A-D) 84 genes were quantified in duplicates from two different animals of each genotype using a 
mouse fibrosis PCR array. (A) The color code indicates the extent of change between knockout and 
wild-type mice (set as 1.0). (B-D) Relative expression of genes relevant for collagen assembly is 
shown in detail. Relative expression of BMP-1/mTLD mRNA in the skin of Mep1a
-/-
 and Mep1b
-/-
 mice 
(E) and in corresponding primary fibroblasts (F) was analyzed by quantitative real-time PCR. 
(*p<0.05); **p<0.01; ***p<0.001). Error bars show SD, n=3 [40]. 
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MMPs play a key role in ECM remodeling and exhibit proteolytic activity against 
mature type I collagens [54]. In the mass spectrometry based approach TAILS, which 
enables the identification of native protein substrates in cellulo, MMP-1 was identified 
as a substrate for meprin α and meprin β revealing a cleavage site within the catalytic 
domain (Fig. 10A, 10B). Since an intact active site is essential for the catalytic activity 
of MMP-1, it was of interest to analyze whether cleavage by meprins directly affects 
the collagenolytic activity of MMP-1. MMP-1 is secreted as a zymogen and requires 
the removal of its propeptide [55]. The prodomain was displaced from the active site 
by treatment with p-aminophenylmercuric acetate (APMA). Differences in the 
collagenase activity of MMP-1 cleaved by meprin α and meprin β compared to the 
unprocessed enzyme were investigated by activity assays (Fig. 10C). When 
proMMP-1 was first incubated with meprin α or meprin β and subsequently activated 
with APMA, the collagenase activity decreased to 27% and 43%, respectively, 
compared to untreated active MMP-1. Even lower collagenolytic activity of about 13% 
was measured when active MMP-1 was processed by meprin α or meprin β (Fig. 
10C) [40]. Hence, the collagenolytic activity of MMP-1 might be increased in the 
absence of meprin α and meprin β, resulting in reduced collagen deposition in skin of 
meprin α and meprin knockout mice.  
Results and Discussion  45 
 
Figure 10: Influence of meprin α and meprin β on the collagenolytic activity of MMP-1. 
(A) Meprin cleavage site in MMP-1 identified by TAILS [10]. Probability values were calculated by the 
iProphet algorithm, with high confidence in spectrum to peptide assignments. Meprin α or meprin β 
treated cells vs. control cells (ctrl) abundance ratios of >15 identify meprin generated neo-N-termini as 
high confidence cleavage products. Sequences are given in one letter code. For detailed information 
see [10]. (B) Crystal structure of MMP-1 (pdb 2CLT) with the meprin cleavage site (Asp194 in P1’) 
identified by TAILS highlighted in red. The catalytic domain of MMP-1 is show in brown and the 
hemopexin domain in grey. The catalytic zinc in the active site cleft is displayed in orange, complexed 
by three histidines (blue) and one aspartate residue (red). Image produced using the UCSF Chimera 
package from the Resource for Biocomputing, Visualization, and Informatics at the University of 
California, San Francisco (supported by NIH P41 RR-01081)[56]. (C) Relative activity of MMP-1 with 
or without meprin α or meprin β was determined using the fluorogenic peptide MOCAc-Pro-Leu-Gly-
Leu-A2(Dnp)-Ala-Arg-NH2. Proteolytic activity was calculated relative to the emission at 405 nm with 
an excitation at 320 nm [40].  
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3.2 Meprin α and meprin β modulate the release of procollagen from Hsp47 in 
vitro 
The proper assembly of the procollagen I molecules during the transport across 
the Golgi apparatus to the extracellular space is mainly regulated by the procollagen-
binding protein Hsp47 [43]. Interestingly, the proteomics approach TAILS revealed 
two cleavage sites within Hsp47 for meprin α as well as meprin β (Fig. 11A) [10]. 
Incubation of Hsp47 with meprin α or meprin β at pH 7.5 induced a time dependent 
processing of Hsp47 after 30 min (Fig. 11B). However, this processing was limited at 
pH 7.5 and it could be improved at lower pH conditions, leading to a full conversion of 
the full-length Hsp47 by meprin β into the processed form (Fig. 11B).  
To investigate, whether the cleavage of Hsp47 by meprin α and meprin β has 
any effect on the interaction between procollagen and Hsp47, a specific collagen 
binding ELISA was performed. Collagen I was coated on 96-well plates and 
incubated with native or cleaved Hsp47. Indeed, when cleaved by meprin α or meprin 
β, the collagen binding affinity of Hsp47 was up to 5 fold decreased (Fig. 11C). This 
reduction in collagen binding of Hsp47 could be decreased by addition of actinonin, a 
specific meprin α and meprin β inhibitor. Thus, the dissociation of procollagen from 
Hsp47 might be a meprin dependent process in vitro.  
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Figure 11: Meprin α and meprin β cleave Hsp47 and reduce its collagen binding affinity 
in vitro. 
(A) Meprin cleavage site in Hsp47 identified by TAILS [10]. Probability values were calculated by the 
iProphet algorithm, with high confidence in spectrum to peptide assignments. Meprin α or meprin β 
treated cells vs. control cells (ctrl) abundance ratios of >15 identify meprin generated neo-N-termini as 
high confidence cleavage products. Sequences are given in one letter code. [10]. (B) Time and pH 
depended processing of recombinant Hsp47 by meprin α and meprin β. 5 μg Hsp47 were incubated 
with 15 nM recombinant meprin α or meprin β, in a total volume of 10 µl for 1, 30, and 60 minutes at 
37°C, in 20 mM HEPES at pH 7.5, 7.0, 6.5 or 6.0. Proteins were separated by SDS-PAGE under 
reducing conditions and subsequently stained with coomassie. (C) For collagen-binding ELISA rat tail 
collagen was coated on 96-well plates and incubated with the indicated concentration of recombinant 
Hsp47 which was prior processed with 15 nM human recombinant meprin α or meprin β in the 
presence or absence of 10 μM actinonin. Binding was detected as described in [43]. 
 
3.3 Meprin α and meprin β are potential therapeutic targets to limit fibrosis 
The regulation of ECM remodeling depends on complex molecular interactions 
and is therefore a key event in many physiological conditions. A tight balance 
between the synthesis and breakdown of ECM is required for the function of all 
tissues and leads, when dysregulated, to pathophysiological events, such as arthritis, 
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cancer, atherosclerosis, aneurysm and fibrosis [57,58,59,60,61,62,63]. In fibrotic skin 
tissues, such as hypertrophic scars or keloids, an increased synthesis and deposition 
of collagen is observed [64]. However, it is not clearly understood whether the 
excessive accumulations of collagen in fibrotic tissues are due to uncontrolled 
procollagen synthesis, maturation or reduced collagen degradation. 
This work demonstrates that meprin α and meprin β are involved in 
posttranslational modifications of collagens at different levels, as by inducing of the 
release of procollagen from Hsp47 during the secretory pathway, by enzymatic 
conversion of procollagen into fibril forming molecules, and by regulating the activity 
of the collagen degrading enzyme MMP-1. Recently, Kronenberg et al. showed that 
in the dermis of human keloids, both meprin α and meprin β are overexpressed [37]. 
Thus, inhibition of meprins in skin could offer a promising approach for the regulation 
of meprin mediated collagen deposition in fibrotic skin.  
The initial idea for the development of specific meprin α and meprin β inhibitors 
was raised by the finding that meprin β as well as meprin α have a striking preference 
for negatively charged residues at the P1’ position (Fig. 12A) [38]. This cleavage 
specificity was also found to be characteristic for other astacin proteases as the 
procollagen C-proteinase BMP-1. Apart from astacin proteases, no other extracellular 
proteases share this particular substrate motif, suggesting that many cleavage events 
seen in vivo exhibiting negatively charged amino acid residues in P1’ might be due to 
meprin activity, or related family members [3,38]. Moreover, examination of the 
recently solved crystal structure of human meprin β indicated that positively charged 
arginine residues Arg516 and Arg567, both part of the TRAF domain of meprin β can 
interact with negatively charged amino acid residues of the substrate (Fig. 12B) 
[3,12]. Therefore, it seems likely that small molecules resistant to proteolytic cleavage 
with a proper distribution of negatively charged groups might inhibit meprins.  
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Figure 12: Cleavage specificity of meprin α and meprin β. 
(A) Cleavage specificity of meprin α and meprin β displayed in the WebLogo style, where the most 
preferred amino acid residues are shown for positions P6 to P6’. The height of the single letter code 
corresponds to its occurrence. Colour-coding: acidic residues in red, basic residues in blue, polar 
residues (including tyrosine and glycine) in green, hydrophobic residues (including alanine and 
proline) in black. The black line indicates the cleavage site. WebLogo ordinates are scaled in bits as 
described previously [65]. Relative abundance of amino acid residues around the cleavage sites of 
meprin α and meprin β derived from native substrates. (B) The unique specificity of meprin β is based 
on structural features of the active site cleft. Positively charged arginine (Arg) residues (dark blue) can 
interact with negatively charged amino acid residues of the substrate. The catalytic zinc is shown in 
orange, the TRAF domain in brown. Numbering of amino acids is based on UniProt [3]. 
 
 
To explore which distribution of negatively charged groups leads to the optimal 
binding into the active site cleft, three different acidic quenched fluorogenic hexa-
peptides P1 ((Mca)-EDEDED-(Dnp)), P2 ((Mca)-EEEEEE-(Dnp)), and P3 ((Mca)-
DDDDDD-(Dnp)) were used. These three peptides were incubated with either human 
recombinant meprin α, meprin β or BMP-1 and the relative amount of product (y axis) 
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was calculated with regard to fluorescence intensity at 405 nm with an excitation at 
320 nm, and plotted against time in seconds (x axis) [3]. Interestingly, only meprin β 
but not meprin α or BMP-1 were capable of cleaving these acidic peptides (Fig. 13). 
P1 containing both Asp and Glu residues was the best substrate for meprin β [3].  
 
 
Figure 13: Meprin β cleaves completely acidic peptides. 
(A) Quenched fluorogenic peptides (P1, P2, and P3) were incubated with human recombinant meprin 
α or meprin β or (B) BMP-1 and the relative amount of product (y axis) was calculated with regard to 
fluorescence intensity at 405 nm with an excitation at 320 nm, and plotted against time in seconds(x 
axis). Mca: (7-Methyloxycoumarin-4-yl) acetyl; dnp, 2,4-Dinitrophenyl [3]. 
 
To confirm that peptide P1 can be processed by endogenous meprin β it was 
applied in a cell culture based activity assay. MDCK (Madin-Darby Canine Kidney 
Epithelial) cells stably transfected with human meprin β or its catalytically inactive 
mutant E90A were used to determine the cell surface activity of meprin β. Only 
meprin β over-expressing cells were able to hydrolyze the acidic substrate P1 (Fig. 
14A). No activity was detectable on cells overexpressing the inactive E90A mutant 
displaying the ability of endogenous membrane bound meprin β to cleave the 
Asp/Glu stretch. Thus, the application of the quenched fluorogenic peptide P1 
represents a novel tool for determination and quantification meprin β surface activity 
in cell culture based assays. 
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In order to further analyze the processing of the acidic peptide by endogenous 
meprin β, kidney lysates were prepared form wild-type, Mep1b-/+, and Mep1b-/- mice 
in the absence of the metalloprotease inhibitor EDTA. Only in kidney lysates from 
wild-type and heterozygous meprin β knockout mice activity could be detected. In 
kidney lysates of meprin β null mice only very low back-ground activity was 
detectable (Fig. 14B). This residual activity probably resulted from hydrolyzation of 
the peptide P1 by meprin α, since it could be inhibited in Mep1b-/- tissue lysates using 
actinonin (Fig. 15D). Therefore, it seems likely, that in vivo endogenous murine 
meprin α, in contrast to the human recombinant protein is able to hydrolyze the 
Asp/Glu stretch of the peptide P1. However, whether murine meprin α is able to 
cleave P1 is not clear yet and further activity assays using recombinant murine 
meprin α need to be performed to clarify this issue. 
As deduced from the crystal structure of meprin β, the peptide P1 had the ideal 
distribution of negatively charged groups for the interaction with the active site cleft of 
meprin β and is therefore thought to be a good model for the development of an 
inhibitory compound. Moreover, this unique cleavage specificity of meprin β 
demonstrates that the application of P1 is a novel tool for the determination and 
quantification of meprin β activity in vitro and in vivo. Improvement of this technique 
might offer a method to display meprin β activity not only in tissue lysates, but also in 
organs of living organisms. This activity-based imaging and monitoring of meprin β 
activity in vivo would allow an accurate targeting of meprin β directly at the site of its 
action. 
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Figure 14: Endogenous meprin β cleaves acidic peptide P1 in cell culture and in 
kidney lysates. 
(A) Cell surface activity of meprin β was analyzed using MDCK (Madin-Darby Canine Kidney 
Epithelial) cells stably overexpressing meprin β or the catalytically inactive mutant E90A. Equal 
numbers of MDCK cells were seeded in a 24-well plate and were grown until 90% confluence. Cell 
surface activity of meprin β was determined using quenched fluorogenic peptide P1 and the relative 
amount of product (y axis) was calculated with regard to fluorescence intensity at 405 nm with an 
excitation at 320 nm, and plotted against time in seconds (x axis). (B) Meprin activity was measured in 
200 μg kidney lysate after addition of the quenched fluorogenic peptide P1.  
 
The unique cleavage specificity and the structure of meprin β allowed the 
design of specific inhibitors, targeting the active site of this protease. The aim was to 
create a small peptide-inhibitor that is stable towards proteolysis, but still displaying 
the same binding properties as a substrate. This characteristic is fulfilled by 
phosphinic peptide-analogues where the carboxyl group of amino acids is replaced 
by a phosphonic mimic (Fig. 15A). Grams et al. showed, that such phosphinic 
peptides bind into the active site of astacin thereby mimicking the carboxy-anion of 
the transition state therefore being resistant to proteolytic degradation [66]. A 
phosphinic peptide inhibitor, which copies the structural features of the acidic peptide 
P1 was created by Vincent Dive (CEA, Service d’Ingénierie Moléculaire des 
Protéines, Cedex, France). 
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Figure 15: Phosphinic peptide inhibits recombinant and endogenous meprin β. 
(A) Structure of a phosphinic peptide inhibitor. Tetrahedral phosphonic moiety is depicted in red. 
Orange, green, pink and blue circles indicate amino acid side chains (adapted from Vincent Dive 
©CEA/V. Dive). (B) 1-100 nM phosphinic meprin β inhibitor (PMI) was incubated with active meprin β 
for 30 min at 37°C subsequently enzyme activity was measured using the quenched fluorogenic 
peptide P4. The relative amount of product (y axis) was calculated with regard to fluorescence 
intensity at 405 nm with an excitation at 320 nm, and plotted against time in seconds (x axis). (C) 
Equal amount of MDCK cells was seeded in a 24-well plate and were grown until 90% confluence. 100 
nM of the inhibitor was added to 400 µl serum free cell culture medium and cell surface activity of 
meprin β was directly determined. (D) 100 nM phosphinic inhibitor or 10 µM actinonin were added to 
200 μg kidney lysate in a total volume of 100 µl. Meprin activity was immediately measured after 
addition of the quenched fluorogenic peptide P1.  
 
The phosphinic peptide inhibited human recombinant meprin β in low 
nanomolar concentration (Fig. 15B) and cell surface activity of human endogenous 
meprin β on stably transfected MDCK cells could be fully blocked with 100 nM 
inhibitor (Fig. 15C). The same amount of the phosphinic peptide-analogue inhibited 
meprin β activity in murine WT kidney lysates and showed no effect in meprin β 
knockout tissue, indicating the specificity of this inhibitor for endogenous meprin β in 
vivo (Fig. 15D). Interestingly, actinonin which is known to inhibit both, meprin α and 
meprin β induced an even stronger reduction in WT and meprin β deficient tissues 
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(Fig. 15D). Since the phosphinic inhibitor had a less pronounced effect on the 
endogenous meprin activity compared to actinonin it probably inhibited only meprin β 
but not meprin α in murine tissue. Moreover, the phosphinic inhibitor did not reduce 
the activity in meprin β deficient lysates, pointing out the specificity if this inhibitor 
towards endogenous meprin β. 
Meprin β is implicated in many pathological processes such as inflammation, 
neurodegeneration, cancer and fibrosis [3]. This work demonstrates that meprins are 
involved in collagen deposition in skin and the absence of meprin activity 
consequently leads to reduced maturation and deposition of procollagen I along with 
an abnormal collagen fibril organization and reduced tensile strength of the skin. 
Moreover, meprin α and meprin β are overexpressed in dermal fibroblasts of fibrotic 
skin the place of collagen synthesis and maturation [37]. Therefore, it is evident that 
targeting meprin activity in fibrotic skin might allow for the development of a novel 
therapeutic approach to limit collagen deposition in this pathologic condition. Future 
studies using the small inhibitory mimic have to be performed to investigate its 
inhibitory and therapeutic potential in cellulo and in vivo. Bleomycin-induced fibrosis 
mouse models might help to study whether the peptide-analogue is able to inhibit 
meprin’s procollagen C- and N-proteinase activity in vivo and to reduce collagen 
deposition in fibrotic skin. 
3.4 KPI domain of APP751 inhibits the activity of KLK2, KLK4, and KLK7 in 
vitro 
The mechanisms for regulation of a protease’s activity involve endogenous activators 
and inhibitors. Maintenance of tightly regulated processes is crucial and the upset of 
this balance consequently leads to a range of pathological events, such as arthritis, 
cancer, atherosclerosis, aneurysms and fibrosis 
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[57,58,60,61,62,63,67,68,69,70,71,72]. Meprin β is secreted as a zymogen and has 
to be proteolytically processed by tryptic enzymes to gain activity [3]. Ohler et al. 
demonstrated that kallikrein-related serine peptidases (KLKs) 4, 5, and 8 are able to 
activate meprin β by enzymatic removal of its propeptide [5]. The activity of KLKs is 
mainly regulated by canonical inhibitors. The best characterized inhibitors are the 
Kunitz protease inhibitors (KPI) which are known to regulate the activity of a range of 
serine proteases, e.g. trypsin, chymotrypsin, and plasmin [73]. Interestingly, KPI can 
be part of larger proteins, as a functional module within a multi-domain molecule [74]. 
This is the case for the amyloid precursor protein (APP) isoform 751 which 
possesses a KPI-domain (Fig. 16A) [75]. Recently, it was demonstrated that meprin β 
exhibits β-secretase activity, thereby releasing the soluble ectodomain of APP into 
the extracellular space [14]. On the other hand, meprin β activates the α-secretase 
ADAM10, which also sheds APP from the cell surface [10]. Therefore, it was of great 
interest to analyze whether soluble APP751 (sAPP751), containing a functional KPI 
domain is able to inhibit KLKs, consequently regulating the activation of promeprin β.  
Indeed, sAPP751 was able to inhibit KLK2, 4 and 7 in the same manner as the 
recombinant KPI domain (Fig. 16B, 16C). Recombinant sAPP751 inhibited the activity 
of KLK2 and KLK4 down to 20-30%, while the KPI domain alone reduced the activity 
of KLK2 and KLK4 down to 30-40% (Fig. 16B, 16C). After incubation with the 
recombinant KPI domain, KLK7 exhibited only about 40% residual activity. 
Interestingly, no KLK 7 activity could be detected in the presence of sAPP751 (Fig. 
16B, 16C). Inhibition kinetics were determined to analyze affinity of the sAPP751 
towards the KLKs, revealing an IC50 of 9.55 nM, 74.32 nM, and 3.695 nM for KLK2, 
KLK4, and KLK7, respectively.  
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Figure 16: sAPP751 and the KPI domain inhibit the activity of KLK2, KLK4, and KLK7 in 
vitro. 
(A) The soluble ectodomain of APP751 contains a N-terminal domain (N-APP), followed by the KPI 
domain, E2/carbohydrate binding domain and a truncated Aβ domain. (B) Recombinant sAPP751 and 
(C) the KPI domain alone (kind gift from Prof. Dr. Axel J. Scheidig, Institute of Zoology, Christian-
Albrechts-University, Kiel) were incubated with recombinant KLK2, 4 and 7 for 10 min at 37°C in 50 
mM Tris/HCl buffer, pH 8.0, containing 100 mM NaCl and 0.005% Tween 20. All activity assays were 
performed in duplicates in a 96-well plate in a total volume of 100 μl. Activity of KLK2 and KLK4 was 
determined using the quenched fluorogenic peptide Z-Pyr-Gly-Arg-Mca. For KLK7 activity 
measurements the quenched fluorogenic peptide Suc-Leu-Leu-Val-Tyr-AMC was applied.  
 
Kunitz serine protease inhibitors are characterized by their resistance to 
proteolysis through a disulfide-stabilized double loop structure. The KPI is able to 
bind the active site of the target enzymes in a substrate-like manner, since the 
reactive peptide bond is orientated ideally for proteolytic cleavage [76]. However, this 
noncovalent complex consisting of 3 disulfide bonds persists being resistant to 
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proteolysis. The KPI domain is often expressed as a functional module within a multi-
domain protein such as APP751.  
Full-length APP751 is a transmembrane protein which is expressed in the basal 
layer of epidermis where it fulfills a variety of distinct biological roles [77,78]. sAPPα, 
generated by the metalloprotease ADAM10, has been demonstrated to be a potent 
epidermal growth factor due to its mitogenic activity [77]. Interestingly, meprin β has 
previously been shown to activate ADAM10 through cleavage of the propeptide [10]. 
When active, ADAM10 releases sAPPα that might than interact with other soluble 
serine proteases such as KLK2, KLK4, and KLK7 thereby regulating their activity 
within this proteolytic web (Fig. 3, 17). Additionally, meprin β itself is able to act as β-
secretase, also being able to release the ectodomain of APP into the extracellular 
space [14]. Ohler et al. postulated, that in skin KLK4 activates meprin β by proteolytic 
removal of its propeptide [5]. Once activated, meprin β induces terminal 
differentiation of keratinocytes in skin [22]. Thus, when inhibited through sAPP751, 
KLK4 is not able to cleave off the propeptide of promeprin β and promeprin β remains 
in its inactive state, unable to induce APP ectodomain shedding. This negative 
feedback loop might be relevant for the regulating of the cell cycle and differentiation 
of keratinocytes where both proteases meprin β and ADAM10 seem to be important 
players. However, this has to be studied in detail in cell culture based assays and 
investigations have to be performed to understand the effect of meprin mediated 
sAPP release within the proteolytic web. For instance, mass spectrometry analyses 
of the secretome of APP knockdown keratinocytes could help to understand the 
regulatory role of sAPP in skin. Moreover, in addition to meprin β induced 
ectodomain shedding of APP, meprin β processes APP at the N-terminus, generating 
N-APP fragments. Whether this cleavage has any effects on the inhibitory capacity of 
sAPP751 has to be elucidated in further inhibition studies.  
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Figure 17: Negative feedback regulation of meprin β activity within the proteolytic web. 
Promeprin β can be activated by human tissue KLKs. When active, membrane-bound meprin β 
generates soluble APP which in turn affects the activity of KLKs. On the other hand meprin β activates 
the constitutive α-secretase ADAM10 [10] which performs ectodomain shedding of APP, thereby 
indirectly regulating meprin β activity.  
 
3.5 Development of a specific sandwich ELISA for detection of meprin α  
In order to generate monoclonal antibodies (mAb) against meprin α, BALB/c 
mice were immunized with human recombinant promeprin α with a N-terminal Strep-
tag as previously described [44]. Supernatants of hybridoma cells were tested for 
production of anti-meprin α mAb by ELISA. Eighteen positive clones were obtained 
(M41-1 to M41-18) and tested for antigen recognition by Western blotting. Western 
blot analyses revealed that all generated mAb were able to recognize recombinant 
meprin α (Fig. 18). Interestingly, anti-meprin α mAbs M41-1, M41-3, and M41-5 were 
able to bind an epitope within the pro-domain of meprin α, thereby recognizing only 
the recombinant promeprin α (Fig. 18, 19).  
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Figure 18: Western blot analysis of recombinant human meprin α using mAb produced 
by the hybridoma clones M41-1 to M41-18. 
0.5 μg pro and active meprin α was separated by SDS-PAGE under reducing conditions and 
subsequently transferred to PVDF membrane. Supernatants of the hybridoma cells M41-1 – M41-18 
were used for detection of recombinant human meprin α. 
 
Three of the eighteen positive hybridoma cell lines M41-5, M41-14, and M41-15 
containing secreted meprin α mAb were selected for further analyses. To confirm that 
selected antibodies specifically detect meprin α, they were tested for cross-reactivity 
with other astacin proteases. As deduced from the Western blot (Fig. 19), none of the 
tested mAbs cross-reacted neither with other recombinant astacin proteases, nor with 
the Strep-tag of promeprin α.  
 
Figure 19: Cross-reactivity analysis of recombinant human meprin α using mAb 
produced by the hybridoma cells M41-5, M41-14, and M41-15. 
 
0.5 μg human recombinant pro and active meprin α or meprin β, BMP-1, astacin, and the Strep-tagged 
LAST-MAM were separated by SDS-PAGE under reducing conditions and subsequently transferred to 
PVDF membrane. Supernatants of the hybridoma cells M41-5, M41-5, M41-14, and M41-15 were 
used for detection of the proteins. Asterisk represents the molecular weight marker band of 80 kDa.  
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Recently it became evident, that meprins, especially meprin α, play a role in 
inflammation and cancer [3]. Therefore, a specific meprin α sandwich ELISA has 
been established for the detection of meprin α protein concentration in human serum. 
Among the generated hybridoma cells, the clones M41-14 and M41-15 produced 
mAbs which recognized the endogenous and native meprin α (Fig. 20A, 20B). 
Therefore these mAbs were purified and further used to establish a meprin α specific 
sandwich ELISA. 
 
Figure 20: Immunoprecipitation of meprin α using mAbs produced by hybridoma cells. 
(A) Western blot analysis of immunoprecipitated recombinant meprin α, and (B) endogenous meprin α 
from the supernatants of CaCo-2 cells. Proteins were separated by SDS-PAGE under reducing 
conditions and subsequently transferred to PVDF membrane. mAb M41-14 was used for detection of 
the proteins. Asterisk marks unspecific protein signals. 
A sandwich ELISA specific for human meprin α was developed, where ELISA plates 
were coated with purified M41-15 and the antigen was detected with the biotinylated 
M41-14. Application of the capture antibody M41-15 and biotinylated detection 
antibody M41-14 enabled the detection of meprin α to a concentration of 4 ng/ml (Fig. 
21A). The overexpression of meprin α is associated with many inflammatory 
processes [3]. Interestingly, in human sera obtained from patients suffering from 
rheumatoid arthritis, a chronic, inflammatory autoimmune disease, 20 ng/ml meprin α 
could be detected while meprin α serum levels in healthy donors were below the 
sensitivity of this ELISA (Fig. 21B).  
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Figure 21: Sandwich ELISA using mAb M41-15 as capture antibody and biotinylated 
mAb M41-14 for detection of human meprin α.  
96-well plates coated with 10 µg/ml of mAb M41-15 and were incubated with (A) 4-3000 ng/ml human 
recombinant meprin α for 2 h at RT. Biotinylated M41-14 was added at a final concentration of 1 µg/ml. 
The detection of biotinylated antibody has been performed using horseradish peroxidase-labeled 
streptavidin and BM blue as substrate. (B) 100 μl cell culture medium from HEK293 cell untransfected 
or transiently transfected with human meprin α or 100 μl serum of healthy or arthritis donors were 
applied on 96-well plates coated with 10 µg/ml of mAb M41-15. After incubation for 2 h at RT 
biotinylated M41-14 was added at a final concentration of 1 µg/ml and the detection has been 
performed using horseradish peroxidase-labeled streptavidin and BM blue as substrate. 
 
 
Recently, a mass spectrometry based proteomics approach revealed increased 
serum and urine levels of meprin α in Kawasaki diseased patients [79]. Kawasaki 
disease is an acute vasculitis in children which causes inflammation in arteries 
throughout the body and is therefore the leading cause of heart disease in children 
[80]. A late diagnosis and treatment often leads to morbidity and mortality. Therefore, 
a sensitive ELISA for detection of meprin α in human serum or urine might represent 
a helpful tool for early diagnosis of Kawasaki disease disease or other inflammatory 
disorders.  
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4 Perspective 
Fibrosis is a pathological accumulation of fibrillar collagen in tissue and 
represents a major global disease. It frequently results upon wound healing 
processes in almost any organ or tissue of the body [64]. The development of anti-
fibrotic drugs is a major goal in biomedical research, which requires knowledge of all 
molecular mechanisms implicated in the massive collagen deposition in the ECM of 
connective tissues in fibrosis. Several post-translational key events during synthesis, 
maturation, deposition and degradation of fibrillar collagen can be targeted. This work 
demonstrates that meprin α and meprin β are involved in posttranslational 
modifications of collagens at different levels, by inducing of the release of 
procollagen from Hsp47 during the secretory pathway, by enzymatic conversion of 
procollagen into fibril forming molecules, and by regulating the activity of the collagen 
degrading enzyme MMP-1. Meprins are the first known procollagen I N- and C-
proteinases in vivo and they induce the assembly and deposition of collagen I in skin. 
Regulating the activity of enzymes responsible for the maturation of procollagen is a 
suitable antifibrotic strategy for the therapeutic treatment of fibrosis [81]. Thus, 
inhibition of meprins in skin is a promising approach for the regulation of pathological 
collagen deposition in fibrotic skin. 
In addition, directed inhibition of meprins might regulate the activity of MMP-1, 
the proteolytic enzyme which is responsible for the degradation of type I collagen and 
important target in fibrosis. In keloid lesions Hsp47 is highly up-regulated suggesting 
its role in the rapid and extensive synthesis of collagen in these tissues. Inhibition of 
meprins might reduce the secretion of collagen into the ECM and might be beneficial 
for the therapeutic treatment of fibrosis.  
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The application of proteomics helped to identify meprins as novel players in 
collagen assembly and to design specific inhibitor compounds to target these 
proteolytic enzymes in vitro and in vivo. In future, cell-culture studies and animal 
models will help to understand how these proteases are integrated within the 
protease web under physiological and pathological conditions and whether the 
regulation of their proteolytic activity by using small inhibitory compounds is beneficial 
for the therapeutic treatment of fibrosis. 
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6 Appendix 
6.1 Abbreviations  
ADAM a disintegrin and metalloprotease 
ADAMTS a disintegrin and metalloprotease with thrombospondin motifs 
AD Alzheimer’s Disease 
APMA p-aminophenylmercuric acetate 
APP amyloid precursor protein 
Aβ amyloid β peptide 
BACE1 β-site-APP-cleaving-enzyme 
BCA bicinchoninic acid 
BMP-1 bone morphogenetic protein 1 
b bases 
BSA bovine serum albumin  
°C degree celsius 
CaCo-2 Caucasian colon adenocarcinoma cells 
C- carboxy- 
cDNA complementary DNA 
CP C-propeptide 
C-telo C-telopeptide 
Da dalton 
dH2O distilled water 
DMEM Dulbecco Minimal Essential Medium 
DMSO dimethyl sulfoxide 
DNA desoxyribonucleic acid 
Dnp 2,4-Dinitrophenyl 
DTT dithiothreitole 
DR6 death receptor 6 
E2 conserved region of the central APP domain  
ECM extracellular matrix 
EGF Epidermal Growth Factor 
ELISA enzyme linked immunosorbent assay 
ER endoplasmic reticulum 
FCS fetal calf serum 
h hours 
HaCaT human adult low calcium high temperature keratinocytes 
HEK human embryonic kidney 
Hsp heat shock protein 
I inserted 
k kilo 
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KLK kallikrein 
KPI Kunitz protease inhibitor 
l liter 
LEKTI Lympho-epithelial Kazal-type-related inhibitor 
M molar 
Mab monoclonal antibody 
MAM meprin A5 protein, receptor tyrosine phosphatase μ 
Mca 7-Methyloxycoumarin-4-yl) acetyl 
MDCK Madin-Darby Canine Kidney Epithelial 
MEF mouse embryonic fibroblasts 
Mep meprin 
meprin metalloprotease from renal tissue 
min minute 
MMP matrix metalloprotease 
mRNA messenger RNA 
mTld mammalian tolloid 
n nano 
N- amino- 
Np N-propeptide 
N-telo N-telopeptide 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCPE-1 procollagen 1 C-proteinase enhancer 
PCP procollagen C-proteinase 
PCR polymerase chain reaction 
PICS proteomic identification of protease cleavage sites 
PNP procollagen N-proteinase 
PVDF polyvinylidene fluoride 
rpm rotations per minute 
s soluble 
SDS sodium dodecyl sulfate 
sec second 
SLPI secretory leukocyte protease inhibitor 
TAILS terminal amine isotopic labeling of substrates 
TIMP tissue inhibitors of metalloproteases 
TRAF tumor-necrosis-factor-receptor associated factor 
Tll toll-like 
U373 glioblastoma-astrocytoma cells 
WT wild-type 
µ mycro 
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